Yamagiwa Y - Search Results

1

Inhibition of cholangiocarcinoma growth by tannic acid.

Marienfeld C, Tadlock L, Yamagiwa Y, Patel T. Marienfeld C, et al. Among authors: yamagiwa y. Hepatology. 2003 May;37(5):1097-104. doi: 10.1053/jhep.2003.50192. Hepatology. 2003. PMID: 12717390

2

Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.

Meng F, Yamagiwa Y, Ueno Y, Patel T. Meng F, et al. Among authors: yamagiwa y. J Hepatol. 2006 Jun;44(6):1055-65. doi: 10.1016/j.jhep.2005.10.030. Epub 2005 Dec 13. J Hepatol. 2006. PMID: 16469407 Free PMC article.

3

Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes.

Yamagiwa Y, Meng F, Patel T. Yamagiwa Y, et al. Life Sci. 2006 Apr 18;78(21):2494-502. doi: 10.1016/j.lfs.2005.10.015. Epub 2005 Dec 5. Life Sci. 2006. PMID: 16336976 Free PMC article.

4

IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway.

Meng F, Yamagiwa Y, Taffetani S, Han J, Patel T. Meng F, et al. Among authors: yamagiwa y. Am J Physiol Cell Physiol. 2005 Oct;289(4):C971-81. doi: 10.1152/ajpcell.00081.2005. Epub 2005 May 25. Am J Physiol Cell Physiol. 2005. PMID: 15917303 Free PMC article.

5

Translational regulation of XIAP expression and cell survival during hypoxia in human cholangiocarcinoma.

Marienfeld C, Yamagiwa Y, Ueno Y, Chiasson V, Brooks L, Meng F, Patel T. Marienfeld C, et al. Among authors: yamagiwa y. Gastroenterology. 2004 Dec;127(6):1787-97. doi: 10.1053/j.gastro.2004.09.002. Gastroenterology. 2004. PMID: 15578516

6

Translational regulation of x-linked inhibitor of apoptosis protein by interleukin-6: a novel mechanism of tumor cell survival.

Yamagiwa Y, Marienfeld C, Meng F, Holcik M, Patel T. Yamagiwa Y, et al. Cancer Res. 2004 Feb 15;64(4):1293-8. doi: 10.1158/0008-5472.can-03-2517. Cancer Res. 2004. PMID: 14973058

7

Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growth.

Yamagiwa Y, Marienfeld C, Tadlock L, Patel T. Yamagiwa Y, et al. Hepatology. 2003 Jul;38(1):158-66. doi: 10.1053/jhep.2003.50257. Hepatology. 2003. PMID: 12829998

8

Double-stranded RNA activates a p38 MAPK-dependent cell survival program in biliary epithelia.

Tadlock L, Yamagiwa Y, Marienfeld C, Patel T. Tadlock L, et al. Among authors: yamagiwa y. Am J Physiol Gastrointest Liver Physiol. 2003 Jun;284(6):G924-32. doi: 10.1152/ajpgi.00355.2002. Epub 2003 Jan 22. Am J Physiol Gastrointest Liver Physiol. 2003. PMID: 12540369

9

Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest.

Tadlock L, Yamagiwa Y, Hawker J, Marienfeld C, Patel T. Tadlock L, et al. Among authors: yamagiwa y. Am J Physiol Cell Physiol. 2003 Aug;285(2):C277-85. doi: 10.1152/ajpcell.00550.2002. Epub 2003 Mar 19. Am J Physiol Cell Physiol. 2003. PMID: 12646415

10

Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma.

Matsuda Y, Yamagiwa Y, Fukushima K, Ueno Y, Shimosegawa T. Matsuda Y, et al. Among authors: yamagiwa y. Hepatol Res. 2008;38(11):1098-111. doi: 10.1111/j.1872-034X.2008.00387.x. Epub 2008 Aug 5. Hepatol Res. 2008. PMID: 18684128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results